Hormonal Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Hormonal Contraceptive Market is segmented by Product (Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, and Others), Hormone (Progestin Only and Combined Hormone Contraceptives), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Hormonal Contraceptives Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Hormonal Contraceptives Market Size

Hormonal Contraceptives Market Size
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 4.00 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Global Hormonal Contraceptives Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Hormonal Contraceptives Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Hormonal Contraceptives Market Analysis

The Global Hormonal Contraceptives Market is expected to register a CAGR of 4% during the forecast period.

COVID-19 impacted the studied market. For instance, the article titled "Did COVID-19 Impact Contraceptive Uptake? Evidence from Senegal, West Africa" published in Studies in Family Planning in April 2022 stated that during the first wave of COVID-19 in March 2020, there was an immediate decrease in the number of new acceptors overall, and for new users of implants and injectables and oral contraceptive pills (OCPs). The overall trend in monthly new family planning acceptors increased from March - December 2020. Hence COVID-19 had an adverse impact in the beginning but as the situation worldwide normalized, the hormonal contraceptive market started to pace up.

In addition, increasing focus on family planning, favorable regulations by the government, and advancements in hormonal contraception are actively affecting the growth of the studied market.

The need to prevent unintended pregnancy and urbanization coupled with user awareness is projected to boost market growth over the forecast period. For instance, The Department of Economic and Social Affairs, World Fertility and Family Planning 2020 report, stated that globally, women have fewer babies, but fertility rates were high in some parts of the world. The 2030 Agenda for Sustainable Development has a goal that is pertinent to family planning and fertility under objective, which comprises a number of aims to protect the population's health and well-being. In accordance with Target 3.7, all people is likely to have access to family planning, informational and educational materials, and programs that incorporate reproductive health into national policies and plans by the year 2030. Thus, the awareness and government initiatives on family planning is likely to results in an increased demand of contraceptives, which is ultimately projected to boost the market.

Furthermore, the article titled "The United States Government and International Family Planning & Reproductive Health Efforts" published in Kaiser Family Foundation in November 2021 stated that worldwide, 218 million women have an unmet need for modern contraception. The high demand of contraceptive worldwide is anticipated to boost the market during the forecast period.

The company's efforts in producing innovative hormonal contraceptives and enhanced efficiency are anticipated to boost the usage of hormonal contraceptives in the near future. For instance, in April 2021, the Food and Drug Administration approved a combination of drospirenone and estetrol tablet Nextstellis marketed by Mayne Pharma for preventing pregnancy, one of the first combination pills containing naturally occurring estrogen. Such approvals are projected to augment the market growth.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, the availability of alternative contraceptive methods and health risks associated with hormonal contraception are likely to impede market growth.

Hormonal Contraceptives Industry Overview

The hormonal contraceptives market is fragmented in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. The key market players are Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc., Viatris Inc (Mylan N.V.), Bayer AG, Agile Therapeutics, Novartis AG, Johnson & Johnson Private Limited, and Piramal Enterprises Ltd. among others.

Hormonal Contraceptives Market Leaders

  1. Allergan plc

  2. Afaxys, Inc.

  3. Merck & Co., Inc.

  4. Pfizer Inc.

  5. Mylan N.V.

  6. *Disclaimer: Major Players sorted in no particular order
Picture2.png
Need More Details on Market Players and Competiters?
Download PDF

Hormonal Contraceptives Market News

  • In July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA launched NEXTSTELLIS (14.2 mg of estetrol and 3 mg drospirenone tablets), one of the first types of such oral contraceptive with a novel estrogen in Australia.
  • In January 2022, the National Population and Family Planning Agency launched progestin, a safe birth control pill for nursing mothers for breastmilk production and encourage exclusive breastfeeding, which can help avoid infant stunting.

Hormonal Contraceptives Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Focus on Family Planning and Favorable Regulations by Government
    • 4.2.2 Advancements in Hormonal Contraception
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alternative Contraceptive Methods
    • 4.3.2 Health Risks Associated With Hormonal Contraception
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Oral Contraceptives
    • 5.1.2 Skin Patches
    • 5.1.3 Intrauterine Devices
    • 5.1.4 Hormonal Implants
    • 5.1.5 Others
  • 5.2 By Hormone
    • 5.2.1 Progestin Only
    • 5.2.2 Combined Hormone Contraceptives
  • 5.3 By Distribution Channel
    • 5.3.1 Hospital Pharmacies
    • 5.3.2 Retail Pharmacies
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan plc
    • 6.1.2 Afaxys, Inc.
    • 6.1.3 Merck & Co., Inc.
    • 6.1.4 Pfizer Inc.
    • 6.1.5 Mylan N.v.
    • 6.1.6 Bayer AG
    • 6.1.7 Agile Therapeutics
    • 6.1.8 Novartis AG
    • 6.1.9 Johnson & Johnson
    • 6.1.10 The Piramal Group
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Hormonal Contraceptives Industry Segmentation

As per the scope of the report, hormonal contraceptives are one of the birth control methods that act on the endocrine system. This includes using hormones such as progesterone and estrogen to prevent pregnancy by preventing ovulation. The report covers contraceptives that contain hormones, prevents ovulation and pregnancy, and maybe pharmaceutical or medical device. The Hormonal Contraceptive Market is segmented by Product (Oral Contraceptives, Skin Patches, Intrauterine Devices, Hormonal Implants, and Others), Hormone (Progestin Only and Combined Hormone Contraceptives), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Oral Contraceptives
Skin Patches
Intrauterine Devices
Hormonal Implants
Others
By Hormone Progestin Only
Combined Hormone Contraceptives
By Distribution Channel Hospital Pharmacies
Retail Pharmacies
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Hormonal Contraceptives Market Research FAQs

What is the current Global Hormonal Contraceptives Market size?

The Global Hormonal Contraceptives Market is projected to register a CAGR of 4% during the forecast period (2025-2030)

Who are the key players in Global Hormonal Contraceptives Market?

Allergan plc, Afaxys, Inc., Merck & Co., Inc., Pfizer Inc. and Mylan N.V. are the major companies operating in the Global Hormonal Contraceptives Market.

Which is the fastest growing region in Global Hormonal Contraceptives Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Hormonal Contraceptives Market?

In 2025, the North America accounts for the largest market share in Global Hormonal Contraceptives Market.

What years does this Global Hormonal Contraceptives Market cover?

The report covers the Global Hormonal Contraceptives Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Hormonal Contraceptives Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Global Hormonal Contraceptives Industry Report

Statistics for the 2025 Global Hormonal Contraceptives market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Hormonal Contraceptives analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.